Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-25-000484
Filing Date
2025-05-15
Accepted
2025-05-15 14:33:13
Documents
78
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q aagh10q033125.htm   iXBRL 10-Q 921827
2 EXHIBIT 31.1 aaghex31-1.htm EX-31.1 10391
3 EXHIBIT 31.2 aaghex31-2.htm EX-31.2 10392
4 EXHIBIT 32.1 aaghex32-1.htm EX-32.1 3710
5 EXHIBIT 32.2 aaghex32-2.htm EX-32.2 3527
  Complete submission text file 0001185185-25-000484.txt   5878433

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE aagh-20250331.xsd EX-101.SCH 58709
7 XBRL CALCULATION FILE aagh-20250331_cal.xml EX-101.CAL 36739
8 XBRL DEFINITION FILE aagh-20250331_def.xml EX-101.DEF 261256
9 XBRL LABEL FILE aagh-20250331_lab.xml EX-101.LAB 443276
10 XBRL PRESENTATION FILE aagh-20250331_pre.xml EX-101.PRE 281289
81 EXTRACTED XBRL INSTANCE DOCUMENT aagh10q033125_htm.xml XML 706835
Mailing Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803
Business Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803 (888) 988-1333
America Great Health (Filer) CIK: 0001098009 (see all company filings)

EIN.: 980178621 | State of Incorp.: CA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-27873 | Film No.: 25951513
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)